{
    "nctId": "NCT03817359",
    "briefTitle": "Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery",
    "officialTitle": "Use of a Remifentanil-propofol Mixture in Patients With Breast Cancer Undergoing Breast Cancer Surgery: a Prospective Pilot Study",
    "overallStatus": "COMPLETED",
    "conditions": "Anesthetics, Remifentanil, Propofol",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 84,
    "primaryOutcomeMeasure": "Frequency of TCI device adjustments",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* ASA II or III\n* age more than 18 years\n* scheduled for breast cancer surgery under general anesthesia.\n\nExclusion Criteria:\n\n* previously allergic to propofol or remifentanil\n* combining other surgical procedure leading to extended operative time",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}